Resveratrol Inhibits IL-6-Induced Transcriptional Activity of AR and STAT3 in Human Prostate Cancer LNCaP-FGC Cells

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Nutraceuticals for prostate cancer chemoprevention: from molecular mechanisms to clinical application

(2013) Zhijun Wang et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Interleukin-6 signaling pathway in targeted therapy for cancer

(2012) Yuqi Guo et al.   CANCER TREATMENT REVIEWS

Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer

(2012) S Ha et al.   ONCOGENE

Inhibitory mechanisms of the transcriptional activity of androgen receptor by resveratrol: Implication of DNA binding and acetylation of the receptor

(2010) Naoki Harada et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Pim1 Regulates Androgen-Dependent Survival Signaling in Prostate Cancer Cells

(2010) H.G. van der Poel et al.   UROLOGIA INTERNATIONALIS

Interleukin-6 Regulates Androgen Synthesis in Prostate Cancer Cells

(2009) J. Y. Chun et al.   CLINICAL CANCER RESEARCH

Repressive Effects of Resveratrol on Androgen Receptor Transcriptional Activity

(2009) Wen-feng Shi et al.   PLoS One

Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives

(2008) Joydeb Kumar Kundu et al.   CANCER LETTERS

The PIM1 Kinase Is a Critical Component of a Survival Pathway Activated by Docetaxel and Promotes Survival of Docetaxel-treated Prostate Cancer Cells

(2008) Marina Zemskova et al.   JOURNAL OF BIOLOGICAL CHEMISTRY